» Articles » PMID: 27209416

JAK2, MPL, and CALR Mutations in Children with Essential Thrombocythemia

Citing Articles

Absence of canonical mutations in pediatric essential thrombocytosis: a case series.

Lee J, Jo S, Yoo J, Kim S, Chung N, Cho B Blood Res. 2024; 59(1):32.

PMID: 39414685 PMC: 11484992. DOI: 10.1007/s44313-024-00036-4.


Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort.

Fu R, Dong H, Gu W, Meng K, Sun T, Liu X Leukemia. 2024; 39(1):155-165.

PMID: 39375514 DOI: 10.1038/s41375-024-02432-2.


Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide survey.

Ishida H, Miyajima Y, Hyakuna N, Hamada S, Sarashina T, Matsumura R EJHaem. 2022; 1(1):86-93.

PMID: 35847744 PMC: 9175656. DOI: 10.1002/jha2.39.


Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review.

Ianotto J, Curto-Garcia N, Lauermanova M, Radia D, Kiladjian J, Harrison C Haematologica. 2019; 104(8):1580-1588.

PMID: 30679326 PMC: 6669170. DOI: 10.3324/haematol.2018.200832.

References
1.
Fu R, Zhang L, Yang R . Paediatric essential thrombocythaemia: clinical and molecular features, diagnosis and treatment. Br J Haematol. 2013; 163(3):295-302. DOI: 10.1111/bjh.12530. View

2.
Rumi E, Pietra D, Ferretti V, Klampfl T, Harutyunyan A, Milosevic J . JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 2013; 123(10):1544-51. PMC: 3945864. DOI: 10.1182/blood-2013-11-539098. View

3.
Giona F, Teofili L, Capodimonti S, Laurino M, Martini M, Marzella D . CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence. Blood. 2014; 123(23):3677-9. DOI: 10.1182/blood-2014-04-572040. View